Physician profile
Matthew Bean
NPI 1841605862
$2,291.68
in general payments reported to CMS, 2019-2025
23 companies · $46.33 in 2025
The $46.33 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $638 · 2022: $674 · 2023: $462 · 2024: $471 · 2025: $46.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $979.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $769.01 | 2022-2025 | Floseal, Tisseel, Ostene |
| Zimmer Biomet Holdings, INC. | $301.98 | 2021 | |
| Zimvie INC. | $180.59 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $174.72 | 2021-2024 | Relistor |
| Amgen INC. | $139.04 | 2021-2025 | Evenity, Prolia |
| Medtronic, INC. | $104.38 | 2021-2023 | Intellis Adaptivestim |
| Pacira Therapeutics, INC. | $73.33 | 2021 | |
| Bioventus LLC | $68.37 | 2022-2023 | Bonescalpel, Durolane |
| Radius Health, INC. | $57.77 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $56.80 | 2022-2023 | Seglentis |
| Djo, LLC | $46.46 | 2024 | Cmf |
| Valinor Pharma, LLC | $45.63 | 2024-2025 | Movantik |
| Arbor Pharmaceuticals, INC. | $43.82 | 2021 | |
| Forte Bio-Pharma LLC | $30.97 | 2024 | Prolate, Nalocet |
| Trilliant Surgical LLC. | $28.71 | 2024 | 3s Hemi Implant, Large, Non-Sterile |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $27.86 | 2024 | |
| Becton, Dickinson and Company | $24.09 | 2024 | Arista Ah Flexitip |
| Collegium Pharmaceutical, INC. | $23.51 | 2024 | Xtampza |
| Boston Scientific Corporation | $22.34 | 2024 | |
| Curonix LLC | $21.14 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Relievant Medsystems, INC. | $19.14 | 2022 | |
| Smith+Nephew, INC. | $18.72 | 2023 | Trigen Intertan |
| Pacira Pharmaceuticals Incorporated | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.